Targeting myeloid chemotaxis to reverse prostate cancer therapy resistanceChristina Guo, Johann S. de Bono, Ursula Vogl et al.|Nature|2023Cited by 119
Advanced Prostate Cancer with ATM Loss: PARP and ATR InhibitorsAntje Neeb, Johann S. de Bono, Nicolás Herranz et al.|European Urology|2020Cited by 118
Characterizing CDK12-Mutated Prostate CancersPasquale Rescigno, Johann S. de Bono, Bora Gürel et al.|Clinical Cancer Research|2020Cited by 100